SEPT9_v2, frequently silenced by promoter hypermethylation,...

Clinical Epigenetics 2020 / 12 Vol. 12; Iss. 1

SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells

Jiang, Yu, Liu, Lei, Xiang, Qin, He, Xiaoqian, Wang, Yan, Zhou, Dishu, Zou, Can, Chen, Qian, Peng, Mingyu, He, Jin, Jiang, Xianyao, Xiang, Tingxiu, Yang, Yucheng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Journal:
Clinical Epigenetics
DOI:
10.1186/s13148-020-00833-5
Date:
December, 2020
File:
PDF, 3.05 MB
2020
Conversion to is in progress
Conversion to is failed